Loading...

425 posters, 1 videos, 9 audios, 8 topics, 53 sessions, 340 authors, 286 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

22nd Annual Pain Medicine Meeting 2023

November 10 - 11, 2023 | New Orleans Marriott | New Orleans, Louisiana, USA

22nd Annual Pain Medicine Meeting 2023 banner

4573

STELLATE GANGLION BLOCK AS A TREATMENT MODALITY FOR NERVUS INTERMEDIUS NEURALGIA: A CASE REPORT

Part of Topic

Medically Challenging Cases

- Nervus intermedius neuralgia (NIN) is rare craniofacial neuralgia involving the sensory and parasympathetic fibers of the facial nerve

- Unique Pain Presentation : within in the ear canal and auricle.

- Few reports are published within scientific literature.

Story : 63y male with 10+ year history of right facial allodynia and frequent stabbing sharp right auricular pain secondary to NIN.

PMH : Arthritis, Multiple Sclerosis, Pulmonary Embolus

Current Symptoms : Sharp stabbing pain originating along the upper aspect of his right auricle and radiating into the right jaw, down the lateral aspect of his neck into the supraclavicular and infraclavicular region of the right arm and the right shoulder.

Relevant Medications. : Diclofenac, Gabapentin, Baclofen, Klonopin, Eliquis, Hydrocodone

Interventions (Prior) : 4x ENT Periauricular nerve blocks with Kenalog (“injection inside and around the ear)

Physical Therapy : No Physical therapy

Tests : Brian MRI & MRA of the Head: No abnormalities


Ultrasound Guided Stellate Ganglion Block

- 7 ml of 0.25% bupiv­­acaine with 5 mcg of epinephrine per mL 

- Visual thecarotid(CA), internal jugular(IJ) & the stellate ganglion(SG) identified above the longus coli muscle(LC)  and inferolateral to the carotid.

Results

- 70% Pain Reduction in 2 Month Follow-up

Conclusions

- SGB’s  treat sympathetically mediated pain.

-Effective, Long-Lasting, Safe

- Option for patients who fail medical management.


 

22nd Annual Pain Medicine Meeting 2023 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.